They are the imprint of the needle array.
Radiofrequency microneedling tips hold their needles in a fixed rectangular matrix — commonly 12 or 24 pins on facial tips and 40 on the body tip. Each needle enters the skin and delivers radiofrequency energy, creating a small zone of heat-treated (coagulated) tissue beneath it. Because the spacing is fixed, one pass leaves an evenly spaced grid of tiny points, and overlapping passes lay grids across each other.
So the pattern is not a sign that something unusual happened. It is the geometry of the device showing through the skin. The question is not why there is a pattern — it is how strong it is and how long it stays.
There is no published paper that uses the terms "grid marks", "tracking marks" or "track marks." Searching the medical literature for them returns nothing. There is no incidence figure, no average fade time, and no analysis of risk factors under those names.
One paper comes close. A 2022 open-label study of 29 women followed a commercial post-treatment skincare protocol after a single radiofrequency microneedling session, and 97% reported improvement in redness and/or treatment-site marks at four weeks. That tells you marks exist and patients care about them. It does not quantify them: it was open-label, self-reported, funded around a cosmetic product, and had no control group.
Needle insulation. Insulated needles are coated except at the tip, so energy is released deep and the surface layer is spared. Clementoni 2016 showed this directly under the microscope: with insulated needles, the coagulation zone was a clearly demarcated oval confined to the dermis and not involving the epidermis. Non-insulated needles conduct radiofrequency along the entire shaft, including where the needle passes through the skin surface — which produces thermal injury at each entry point and is the physical basis for a visible dot at every needle site. InMode's own operator manuals describe Morpheus8 pins as coated except the distal 0.5 mm, meaning the energy is released from the tip.
Energy per pin. This is the biggest settings lever. A 2025 dose-response study found a near-linear relationship between energy per needle and the size of the coagulation zone in tissue — a correlation of 0.976. More energy per pin means a bigger heat zone at every point, which means a more visible mark. Note that two of the four authors were affiliated with a device manufacturer. This is a settings issue, not an inevitability.
Skin type and the FDA's own limit. The FDA clearance for the Morpheus8 applicator (K192695) carries an explicit limitation: at energy levels above 62 mJ per pin, use of the applicator is limited to skin types I to IV. The regulator has formally tied energy per pin to skin-type safety. Conservative settings in deeper skin tones are not just a courtesy — they are what the clearance contemplates.
Passes and overlap. Overlapping the array stacks energy where the grids intersect. This is mechanically obvious but has not been measured in any published study.
One thing to hold in mind about all of the research above. Almost none of the published radiofrequency microneedling research used Morpheus8. It comes from Lutronic, Jeisys, Pollogen, Lumenis and unnamed devices, and needle design, depth and energy settings differ between machines — which is exactly what determines how visible the marks are. A PubMed search for Morpheus8 returns 16 records, and no randomised controlled trial of the device was found.
In an analysis of the FDA's postmarket reporting database covering January 2013 to October 2025, textural changes were the largest complication category in radiofrequency microneedling reports: 56 of 224 events, 25.0%. Pigment changes were second at 41 of 224, 18.3%.
Textural change is the closest published label for persistent grid-pattern texture, so it is worth knowing. But read it correctly:
A separate 2024 review of 25 patients referred to a specialist clinic with complications from energy-based procedures — radiofrequency with and without microneedling among the devices involved — documented both hypertrophic and atrophic scarring. Small, single-centre, no denominator, but it establishes that texture problems can reach the point of specialist referral.
No published study gives a fade time for grid marks. What published data does cover is normal early healing:
Clinics commonly say marks fade in two to seven days, sometimes up to two weeks. That has no published source. It may well be right; it has simply never been measured.
The practical takeaway is the threshold rather than the number: published downtime data describes healing over roughly a week. Marks that are still clearly visible well beyond that are outside what the research describes, and warrant a review appointment — not because something has definitely gone wrong, but because that is the point at which someone should look at it rather than wait.
Nothing here is trial-proven, but all of it follows from the mechanism: